The Transcription Factor Cux1 in Cerebellar Granule Cell Development and Medulloblastoma Pathogenesis

[1]  M. O’Connor,et al.  Targeting the DNA Damage Response in Cancer. , 2015, Molecular cell.

[2]  M. Paquet,et al.  RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage , 2014, PLoS biology.

[3]  C. Hawkins,et al.  Overcoming resistance to sonic hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma , 2014, Pediatric blood & cancer.

[4]  P. Campbell,et al.  Inactivating CUX1 mutations promote tumorigenesis , 2013, Nature Genetics.

[5]  Yu-Chieh Wang,et al.  Protein post-translational modifications and regulation of pluripotency in human stem cells , 2013, Cell Research.

[6]  Melissa J. Davis,et al.  Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroups , 2013, Proceedings of the National Academy of Sciences.

[7]  G. Enikolopov,et al.  A population of Nestin expressing progenitors in the cerebellum exhibits increased tumorigenicity , 2013, Nature Neuroscience.

[8]  Zizhen Yao,et al.  Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer , 2013, Epigenetics.

[9]  D. Durocher,et al.  Push back to respond better: regulatory inhibition of the DNA double-strand break response , 2013, Nature Reviews Molecular Cell Biology.

[10]  J. Long,et al.  Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair. , 2013, International journal of oncology.

[11]  P. Carmeliet,et al.  Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma , 2013, Cell.

[12]  Christopher D. Brown,et al.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. , 2013, Blood.

[13]  Olivier De Wever,et al.  Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays , 2012, PloS one.

[14]  E. Iversen,et al.  Charting the Landscape of Tandem BRCT Domain–Mediated Protein Interactions , 2012, Science Signaling.

[15]  Adam Possner,et al.  Cerebellum , 2012, Neurology.

[16]  Laura M. Epple,et al.  Medulloblastoma Exosome Proteomics Yield Functional Roles for Extracellular Vesicles , 2012, PloS one.

[17]  F. Speleman,et al.  Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. , 2012, Neuro-oncology.

[18]  Elaine R. Mardis,et al.  Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.

[19]  Loki Natarajan,et al.  Exact statistical tests for the intersection of independent lists of genes. , 2012, The annals of applied statistics.

[20]  P. Michl,et al.  CUX1 (cut-like homeobox 1) , 2012 .

[21]  Wei Xiao,et al.  Selective tumor killing based on specific DNA-damage response deficiencies , 2012, Cancer biology & therapy.

[22]  R. Dudley,et al.  CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage , 2012, Nucleic acids research.

[23]  K. Vousden,et al.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42 , 2011, The EMBO journal.

[24]  J. Marine,et al.  Reciprocal repression between P53 and TCTP , 2011, Nature Medicine.

[25]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.

[26]  Ian M. Donaldson,et al.  iRefR: an R package to manipulate the iRefIndex consolidated protein interaction database , 2011, BMC Bioinformatics.

[27]  Axel Benner,et al.  FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  P. Northcott,et al.  Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation , 2011, Oncogene.

[29]  Y. Wang,et al.  Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion , 2010, Oncogene.

[30]  Hui Zhou,et al.  Liver‐enriched transcription factors regulate MicroRNA‐122 that targets CUTL1 during liver development , 2010, Hepatology.

[31]  Ralf Metzler,et al.  Single particle tracking in systems showing anomalous diffusion: the role of weak ergodicity breaking. , 2010, Physical chemistry chemical physics : PCCP.

[32]  D. Givol,et al.  Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells , 2010, Oncogene.

[33]  F. Zindy,et al.  Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. , 2010, Cancer research.

[34]  A. Nepveu,et al.  The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion , 2010, Cell adhesion & migration.

[35]  B. Cubelos,et al.  Cux1 and Cux2 Regulate Dendritic Branching, Spine Morphology, and Synapses of the Upper Layer Neurons of the Cortex , 2010, Neuron.

[36]  R. Poulsom,et al.  CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer , 2010, Gut.

[37]  J. Milner,et al.  p53 regulates LIF expression in human medulloblastoma cells , 2010, Journal of Neuro-Oncology.

[38]  K. Herrup,et al.  Cytoplasmic ATM in Neurons Modulates Synaptic Function , 2009, Current Biology.

[39]  Alcalay Ni,et al.  Regulation of cell proliferation and differentiation in the kidney. , 2009 .

[40]  K. Schilling,et al.  Basic molecular fingerprinting of immature cerebellar cortical inhibitory interneurons and their precursors , 2009, Neuroscience.

[41]  S. Baker,et al.  Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency , 2009, Proceedings of the National Academy of Sciences.

[42]  L. Karnitz,et al.  Sonic Hedgehog signaling impairs ionizing radiation–induced checkpoint activation and induces genomic instability , 2008, The Journal of Cell Biology.

[43]  Ian M. Donaldson,et al.  iRefIndex: A consolidated protein interaction database with provenance , 2008, BMC Bioinformatics.

[44]  Dirk Troost,et al.  Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features , 2008, PloS one.

[45]  Tao Sun,et al.  Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. , 2008, Cancer cell.

[46]  B. Cubelos,et al.  Cux‐1 and Cux‐2 control the development of Reelin expressing cortical interneurons , 2008, Developmental neurobiology.

[47]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[48]  E. Galanis,et al.  Treatment of medulloblastoma with a modified measles virus. , 2008, Neuro-oncology.

[49]  F. Robert,et al.  p110 CUX1 Cooperates with E2F Transcription Factors in the Transcriptional Activation of Cell Cycle-Regulated Genes , 2008, Molecular and Cellular Biology.

[50]  Mong-Hong Lee,et al.  Roles for CSN5 in control of p53/MDM2 activities , 2008, Journal of cellular biochemistry.

[51]  Maria L. Rizzo,et al.  Measuring and testing dependence by correlation of distances , 2007, 0803.4101.

[52]  F. Robert,et al.  Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes , 2007, Nucleic acids research.

[53]  G. Salvesen,et al.  Carboxyl-terminal Proteolytic Processing of CUX1 by a Caspase Enables Transcriptional Activation in Proliferating Cells* , 2007, Journal of Biological Chemistry.

[54]  Jane Lee,et al.  The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor , 2007, Nucleic acids research.

[55]  J. Downward,et al.  WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. , 2007, Carcinogenesis.

[56]  C. Mathew,et al.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.

[57]  A. Kho,et al.  Cerebellar ‘transcriptome’ reveals cell-type and stage-specific expression during postnatal development and tumorigenesis , 2006, Molecular and Cellular Neuroscience.

[58]  M. Lozano,et al.  Differentiation-Induced Cleavage of Cutl1/CDP Generates a Novel Dominant-Negative Isoform That Regulates Mammary Gene Expression , 2006, Molecular and Cellular Biology.

[59]  B. Goulet,et al.  A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L , 2006, Biological chemistry.

[60]  P. Rosenberg,et al.  Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2 , 2006, Journal of Medical Genetics.

[61]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[62]  Laurent Sansregret,et al.  The p110 Isoform of the CDP/Cux Transcription Factor Accelerates Entry into S Phase , 2006, Molecular and Cellular Biology.

[63]  C. D'Arrigo,et al.  CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness , 2005 .

[64]  John Quackenbush,et al.  Multiple-laboratory comparison of microarray platforms , 2005, Nature Methods.

[65]  R. McLendon,et al.  Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. , 2005, Cancer research.

[66]  C. Walsh,et al.  Expression of Cux‐1 and Cux‐2 in the subventricular zone and upper layers II–IV of the cerebral cortex , 2004, The Journal of comparative neurology.

[67]  A. Hui,et al.  Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. , 2004, Journal of neurosurgery.

[68]  Sarkis Meterissian,et al.  Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells. , 2002, Cancer research.

[69]  Andrea C Pfeifer,et al.  CASP, the alternatively spliced product of the gene encoding the CCAAT-displacement protein transcription factor, is a Golgi membrane protein related to giantin. , 2002, Molecular biology of the cell.

[70]  Stefan Thurner,et al.  Anomalous diffusion on dynamical networks: a model for interacting epithelial cell migration , 2002, cond-mat/0208382.

[71]  Lisa E. Gralinski,et al.  Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes , 2002, Molecular and Cellular Biology.

[72]  C. Viebahn,et al.  An efficient in situ hybridization protocol for multiple tissue sections and probes on miniaturized slides , 2002, Development Genes and Evolution.

[73]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[74]  N. Moon,et al.  S Phase-Specific Proteolytic Cleavage Is Required To Activate Stable DNA Binding by the CDP/Cut Homeodomain Protein , 2001, Molecular and Cellular Biology.

[75]  J. Caldwell,et al.  Developmental and regional expression of sodium channel isoform NaCh6 in the rat central nervous system , 2000, The Journal of comparative neurology.

[76]  K. Sasaki,et al.  Genetic Alterations in Pediatric Medulloblastomas Detected by Comparative Genomic Hybridization , 1999, Pediatric Neurosurgery.

[77]  G. Vassal,et al.  Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children , 1999, British Journal of Cancer.

[78]  F. Behm,et al.  Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. , 1997, Cancer research.

[79]  A. Stagg,et al.  CASP, a novel, highly conserved alternative-splicing product of the CDP/cut/cux gene, lacks cut-repeat and homeo DNA-binding domains, and interacts with full-length CDP in vitro. , 1997, Gene.

[80]  M. Rivkin,et al.  XcmI-containing vector for direct cloning of PCR products. , 1997, BioTechniques.

[81]  R. Weinberg.  The Cat and Mouse Games That Genes, Viruses, and Cells Play , 1997, Cell.

[82]  B. Vogelstein,et al.  Infrequent p53 gene mutations in medulloblastomas. , 1991, Cancer research.

[83]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[84]  Christopher D. Brown,et al.  CUX 1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia , 2013 .

[85]  V. Gladyshev,et al.  Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression , 2009, Nature Protocols.

[86]  G. V. Vanden Heuvel,et al.  Regulation of cell proliferation and differentiation in the kidney. , 2009, Frontiers in bioscience.

[87]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[88]  Yoav Benjamini,et al.  Microarrays, Empirical Bayes and the Two-Groups Model. Comment. , 2008 .

[89]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[90]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .